A Plan to Conquer U.S. Drug Shortages

By JESSICA DALEY and WAYNE RUSSELL
COVID-19 has focused the nations attention on the risks associated with complex, global supply chains, particularly related to healthcare products and prescription drugs. While supply disruptions of personal protective equipment (PPE) captured headlines, the pandemic also compromised the drug supply chain. With much of the United States generic drugs manufactured overseas, exportation bans coupled with increased global demand created significant challenges for…

Click here to view the original article.